TCI sp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2021-07-02
Share capital
10,000.00 PLN
Activity description

Tci is a Contract Research Organization that provides services including product development, registration, out-licensing of developed medicinal products, pharmaceutical analysis, and bioanalytical services. The company focuses on ensuring quality assurance and timely delivery in its manufacturing services.

Registered address
ul. Kładki 24, 80-822 Gdańsk, Poland
Website
Email
Phone
Electronic delivery address
AE:PL-60113-29798-WETIU-26

Financials

Revenue history (in k)

Filing timeliness

5 of 5 financial statements were filed late (the longest delay 94 days for 2021).

  • 202502/08/2026
  • 202426/07/2025
  • 202327/08/2024
  • 202219/07/2023
  • 202117/10/2022
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 33%
City · Gdańsk3,852 / 7,507
Top 51%
Voivodeship · Pomorskie10,977 / 20,073
Top 55%
Country · Poland161,425 / 297,266
Top 54%

Results vs industry

Revenue
This companyUSD 218.47kMedianUSD 73.13kAverageUSD 3.24m
Net profit
This companyUSD 7.42kMedianUSD 68.58AverageUSD 83.05k
Operating costs
This companyUSD 210.88kMedianUSD 75.83kAverageUSD 3.05m
Assets
This companyUSD 21.63kMedianUSD 120.25kAverageUSD 3.90m

Offer

  • Pharmaceutical testing
  • Formulation development
  • Pharmaceutical analysis
  • Bioanalytical services
  • Medicinal product registration support
  • Pilot manufacturing

Websites

  • tci.plPharmaceutical research and development — TCI Laboratories
    LiteSpeed

Authorized Representatives

Bogdan Banecki age 61 – President
Jan Procek age 39 – Vice President

Manner of representation

The President of the Management Board is authorized to make declarations of will on behalf of the company, or two members of the management board acting jointly.

Supervisory board

Joanna Agnieszka Jakóbkiewicz-Banecka age 55 – Supervisory Board Member
Andrzej Ireneusz Poszewiecki age 50 – Supervisory Board Member
Jędrzej Siciński age 38 – Supervisory Board Member

Ownership

OwnerSharesShare valueStake
96$2,593.1996%
Others
4$108.054%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2021-10-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Simbec-Orion (Pol) sp. z o.o.
CTI Clinical Trial and Consulting Services Poland sp. z o.o.
MT Laboratories sp. z o.o.
MDR Regulator sp. z o.o.
Medicofarma Biotech S.A.
Globe Badania Kliniczne sp. z o.o.
F1 Pharma S.A.
Genelytica sp. z o.o.
GCP-Service International Ltd. & Co. Kg Branch (foreign co.)
Pharmaxi Poland sp. z o.o.

FAQ

Last updated: 2026-08-02